<DOC>
	<DOCNO>NCT02416609</DOCNO>
	<brief_summary>Aim study evaluate low-dose radiotherapy ( LDR ) intensify local effect chemotherapy regimen Gemcitabine Oxaliplatin administer sequentially stereotactic body radiotherapy ( SBRT ) ass safety efficacy combine treatment patient affect locally advanced pancreatic adenocarcinoma ( LAPC ) .</brief_summary>
	<brief_title>lOw-dose Radiotherapy Plus CHemotherapy With gEmox STeReotactic Radiotherapy Advanced pAncreaTic cancEr</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Pathologically confirm adenocarcinoma pancreas Patients unresectable disease base institutional standardized criterion unresectability patient whose disease appear potentially resectable axial CT imaging find unresectable surgery Eastern Cooperative Oncology Group ( ECOG ) performance status ≤ 2 . Age ≥ 18 Patients biliary gastroduodenal obstruction must drainage surgical bypass prior start treatment Patients radiographically assessable disease Adequate bone marrow , hepatic renal function : Hemoglobin &gt; 10.0 g/dL , absolute neutrophil count &gt; 1.5 x 10^9/L , platelet count &gt; 100 x 10^9/L . Aspartate transaminase ( AST SGOT ) alanine transaminase ( ALT SGPT ) ≤ 3 x upper limit normal ( ULN ) . Total bilirubin &lt; 2 mg/dL . Patients elevate bilirubin due obstruction stented bilirubin decrease &lt; 2 mg/dL prior study entry . Creatinine &lt; 3 mg/dL Creatinine clearance &gt; 40 mL/min ( calculate accord Cockroft Gault ) Evidence metastatic disease major viscera peritoneal seed ascites Gastric duodenal obstruction Previous peripheral neuropathy Previous irradiation plan field ; previous chemotherapy pancreatic cancer Malignancy ( within past two year ) except nonmelanomatous skin cancer carcinoma situ cervix , uterus , bladder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Locally advanced pancreatic cancer</keyword>
	<keyword>Stereotactic Body Radiotherapy</keyword>
	<keyword>Chemopotentiator</keyword>
	<keyword>Low dose radiotherapy</keyword>
	<keyword>Hyper-Radiosensitivity</keyword>
</DOC>